BioCentury
ARTICLE | Company News

Acorda licenses rights to Elan's Zanaflex

July 28, 2004 7:00 AM UTC

Acorda (Hawthorne, N.Y.) acquired U.S. sales, marketing and distribution rights to ELN's Zanaflex tizanidine tablets and capsules, which are approved for spasticity, a condition associated with multip...